Hyperfine (Hyperfine) EBIT : $-45.73 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hyperfine EBIT?

Hyperfine's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-10.65 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-45.73 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Hyperfine's annualized ROC % for the quarter that ended in Mar. 2024 was -268.15%. Hyperfine's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -475.50%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Hyperfine's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -5,167.23%.

Hyperfine EBIT Historical Data

The historical data trend for Hyperfine's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyperfine EBIT Chart

Hyperfine Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

-19.97

-23.49

-64.87

-73.87

-48.12

Hyperfine Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial											-13.04	-11.69	-11.76	-11.63	-10.65

Competitive Comparison of Hyperfine's EBIT

For the Medical Devices subindustry, Hyperfine's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hyperfine's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hyperfine's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hyperfine's EV-to-EBIT falls into.

Hyperfine EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-45.73 Mil.

Hyperfine (NAS:HYPR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Hyperfine's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-42.6 * ( 1 - 0% )	/	( (15.416	+	16.357)	/ 2 )
=	-42.6	/	15.8865
=	-268.15 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	94.199	-	3.6	-	( 75.183	-	max(0, 8.768	-	88.908	+	75.183	))
=	15.416

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	85.443	-	5.882	-	( 63.204	-	max(0, 8.767	-	79.69	+	63.204	))
=	16.357

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Hyperfine's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-42.6	/	( ( (2.999 + max(4.2, 0))	+	(3.706 + max(7.013, 0)) )	/	2 )
=	-42.6	/	( ( 7.199	+	10.719 )	/	2 )
=	-42.6	/	8.959
=	-475.50 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(3.189	+	6.582	+	3.012)	-	(3.6	+	2.074	+	2.909)
=	4.2

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(5.343	+	7.298	+	2.95)	-	(5.882	+	1.527	+	1.169)
=	7.013

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Hyperfine's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-45.73	/	0.885
	=	-5,167.23 %

Hyperfine EBIT Related Terms

Thank you for viewing the detailed overview of Hyperfine's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyperfine (Hyperfine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hyperfine Inc (NAS:HYPR) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

351 New Whitfield Street, Guilford, CT, USA, 06437

Website

https://www.hyperfine.io

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. Legacy Hyperfine and Liminal represent two operating segments of the company. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

Executives

Thomas Teisseyre	officer: Chief Operating Officer	C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437
Khan Siddiqui	officer: See Remarks	530 OLD WHITFIELD STREET, GUILFORD CT 06437
Brett Hale	officer: Chief Administrative Officer	C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437
Maria Sainz	director	C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Jonathan M Rothberg	director, 10 percent owner	C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437
Alok Gupta	officer: Chief Financial Officer	530 OLD WHITFIELD STREET, GUILFORD CT 06437
Neela Paykel	officer: Gen Counsel & Corp Secretary	530 OLD WHITFIELD STREET, GUILFORD CT 06437
David D Scott	director, officer: President and CEO	530 OLD WHITFIELD STREET, GUILFORD CT 06437
Ruth A Fattori	director	1303 EAST ALGONQUIN ROAD, SCHAUMBURG IL 60196
Hc Sponsor Llc	10 percent owner	31 HUDSON YARDS, 10TH FLOOR, 28TH FLOOR, NEW YORK NY 10001
Arthur Bruce Cohen	10 percent owner	12 SOUTH MAIN STREET, SUITE #203, NORWALK CT 06854
Healthcor Group, Llc	10 percent owner	31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001
Joseph Patrick Healey	10 percent owner	31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001
R Scott Huennekens	director	C/O VOLCANO CORPORATION, 11455 EL CAMINO REAL, SUITE 460, SAN DIEGO CA 92130
Scott A. White	officer: Chief Commercial Officer	530 OLD WHITFIELD STREET, GUILFORD CT 06437